Return to Home Incidence > Table > Interpret

Interpretation of Incidence Rates Data

Incidence Rate Report for South Carolina by County

Non-Hodgkin Lymphoma (All Stages^), 2015-2019

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by CI*Rank

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Recent Trends - This is an interpretation of the AAPC/APC:

AAPC/APC (95% Confidence Interval) - the change in rate over time


Other Notes


Line by Line Interpretation of the Report


South Carolina6


US (SEER+NPCR)1


Bamberg County6


Barnwell County6


Dorchester County6


Marion County6


Greenville County6


Berkeley County6


Union County6


Pickens County6


Laurens County6


Aiken County6


Charleston County6


Anderson County6


York County6


Lexington County6


Abbeville County6


Horry County6


Sumter County6


Jasper County6


Marlboro County6


Florence County6


Beaufort County6


Georgetown County6


Richland County6


Lancaster County6


Chester County6


Spartanburg County6


Saluda County6


Greenwood County6


Williamsburg County6


Darlington County6


Oconee County6


Kershaw County6


Colleton County6


Newberry County6


Orangeburg County6


Clarendon County6


Fairfield County6


Chesterfield County6


Dillon County6


Cherokee County6


Allendale County6 Calhoun County6 Edgefield County6 Hampton County6 Lee County6 McCormick County6

Notes:
Created by statecancerprofiles.cancer.gov on 12/10/2022 3:42 am.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Allendale, Calhoun, Edgefield, Hampton, Lee, McCormick

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage.
* Data has been suppressed to ensure confidentiality and stability of rate estimates. Counts are suppressed if fewer than 16 records were reported in a specific area-sex-race category. If an average count of 3 is shown, the total number of cases for the time period is 16 or more which exceeds suppression threshold (but is rounded to 3).

Source: SEER and NPCR data. For more specific information please see the table.

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.

When displaying county information, the CI*Rank for the state is not shown because it's not comparable. To see the state CI*Rank please view the statistics at the US By State level.